纵横研报
Ticker Detail

688189.SHG

¥8+0.00% 南新制药 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Hunan Nucien Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceutical Co., Ltd. was founded in 2006 and is based in Guangzhou, China.

MARKET 市值 1.75B CNY 52W ¥5.47 – ¥18.78 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -35.9% ROE -20.0% 营业利润率 -59.9% 净利润率 -111.6%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制